Browse By Cell Line Result Page of OvirusTdb

The total number of records retrieved from this search are 16. Click on ID to see further detail.
IDVirus nameVirus strainVirus genome typeVirus familyVirus genome modificationVirus aloneVirus in combination with drug/radiationImmune gene insertion in viral genomeSource of cell lineOrigin of cell lineCell lineConcentration of cell lineIn-vitro toxicityAssayIn-vitro virus concentrationIn-vitro resultModel organismIn-vivo virus concentrationIn-vivo toxicityIn-vivo resultMode of deliveryPathway inducedImmunogenic effectClinical trialPMID
OV_1924AdenovirusSG600-IL24DNAAdenoviridaeAddition of gene encoding IL24YesNoVirus expressing IL-24 geneInstitute of HCC, Fudan universityHuman liver cancer cell lineMHCC97L1.0E+3 cells per wellNAMTT assay10 MOI90% cell viality after 24 hoursNoNoNA No responseNAVirus induce the apoptosis in HCC cell lineNANA20872968
OV_1925AdenovirusSG600-IL24DNAAdenoviridaeAddition of gene encoding IL24YesNoVirus expressing IL-24 geneInstitute of HCC, Fudan universityHuman liver cancer cell lineMHCC97L1.0E+3 cells per wellNAMTT assay10 MOI70% cell viability after 48 hoursNoNoNA No responseNAVirus induce the apoptosis in HCC cell lineNANA20872968
OV_1926AdenovirusSG600-IL24DNAAdenoviridaeAddition of gene encoding IL24YesNoVirus expressing IL-24 geneInstitute of HCC, Fudan universityHuman liver cancer cell lineMHCC97L1.0E+3 cells per wellNAMTT assay10 MOI60% cell viability after 72 hoursNoNoNA No responseNAVirus induce the apoptosis in HCC cell lineNANA20872968
OV_1927AdenovirusSG600-IL24DNAAdenoviridaeAddition of gene encoding IL24YesNoVirus expressing IL-24 geneInstitute of HCC, Fudan universityHuman liver cancer cell lineMHCC97L1.0E+3 cells per wellNAMTT assay10 MOI30% cell viability after 96 hoursNoNoNA No responseNAVirus induce the apoptosis in HCC cell lineNANA20872968
OV_1936AdenovirusSG600-EGFPDNAAdenoviridaeAddition of gene encoding EGFPYesNoVirus expressing EGFP geneInstitute of HCC, Fudan universityHuman liver cancer cell lineMHCC97L1.0E+3 cells per wellNAMTT assay10 MOI90% cell viabilty after 24 hoursNoNoNA No responseNAVirus induce the apoptosis in HCC cell lineNANA20872968
OV_1937AdenovirusSG600-EGFPDNAAdenoviridaeAddition of gene encoding EGFPYesNoVirus expressing EGFP geneInstitute of HCC, Fudan universityHuman liver cancer cell lineMHCC97L1.0E+3 cells per wellNAMTT assay10 MOI80% cell viability after 48 hoursNoNoNA No responseNAVirus induce the apoptosis in HCC cell lineNANA20872968
OV_1938AdenovirusSG600-EGFPDNAAdenoviridaeAddition of gene encoding EGFPYesNoVirus expressing EGFP geneInstitute of HCC, Fudan universityHuman liver cancer cell lineMHCC97L1.0E+3 cells per wellNAMTT assay10 MOI80% cell viability after 72 hoursNoNoNA No responseNAVirus induce the apoptosis in HCC cell lineNANA20872968
OV_1939AdenovirusSG600-EGFPDNAAdenoviridaeAddition of gene encoding EGFPYesNoVirus expressing EGFP geneInstitute of HCC, Fudan universityHuman liver cancer cell lineMHCC97L1.0E+3 cells per wellNAMTT assay10 MOI70% cell viability after 96 hoursNoNoNA No responseNAVirus induce the apoptosis in HCC cell lineNANA20872968
OV_2562AdenovirusSG600-IL-24DNAAdenoviridaeDeletion of E1B gene and insertion of IL-24 geneYesNoVirus expressing IL-24 geneATCCHuman hepatocellular carcinoma cell lineMHCC97L1000 cellsNAMTT assay10 MOI88.2% cell survival after 24 hoursNoNoNA No responseNACombined therapy increases STAT1, SOCS1 and apoptosisCombined therapy decreases expression of MMP-2, XIAP,OPN and VEGFNA22569271
OV_2563AdenovirusSG600-IL-24DNAAdenoviridaeDeletion of E1B gene and insertion of IL-24 geneYesNoVirus expressing IL-24 geneATCCHuman hepatocellular carcinoma cell lineMHCC97L1000 cellsNAMTT assay10 MOI72.3% cell survival after 48 hoursNoNoNA No responseNACombined therapy increases STAT1, SOCS1 and apoptosisCombined therapy decreases expression of MMP-2, XIAP,OPN and VEGFNA22569271
OV_2564AdenovirusSG600-IL-24DNAAdenoviridaeDeletion of E1B gene and insertion of IL-24 geneYesNoVirus expressing IL-24 geneATCCHuman hepatocellular carcinoma cell lineMHCC97L1000 cellsNAMTT assay10 MOI58% cell survival after 72 hoursNoNoNA No responseNACombined therapy increases STAT1, SOCS1 and apoptosisCombined therapy decreases expression of MMP-2, XIAP,OPN and VEGFNA22569271
OV_2565AdenovirusSG600-IL-24DNAAdenoviridaeDeletion of E1B gene and insertion of IL-24 geneYesNoVirus expressing IL-24 geneATCCHuman hepatocellular carcinoma cell lineMHCC97L1000 cellsNAMTT assay10 MOI28% cell survival after 96 hoursNoNoNA No responseNACombined therapy increases STAT1, SOCS1 and apoptosisCombined therapy decreases expression of MMP-2, XIAP,OPN and VEGFNA22569271
OV_2566AdenovirusSG600-IL-24+IFNDNAAdenoviridaeDeletion of E1B gene and insertion of IL-24 gene and addition of INYesNoVirus expressing IL-24 gene and IFN geneATCCHuman hepatocellular carcinoma cell lineMHCC97L1000 cellsNAMTT assay10 MOI84.3% cell survival after 24 hoursNoNoNA No responseNACombined therapy increases STAT1, SOCS1 and apoptosisCombined therapy decreases expression of MMP-2, XIAP,OPN and VEGFNA22569271
OV_2567AdenovirusSG600-IL-24+IFNDNAAdenoviridaeDeletion of E1B gene and insertion of IL-24 gene and addition of INYesNoVirus expressing IL-24 gene and IFN geneATCCHuman hepatocellular carcinoma cell lineMHCC97L1000 cellsNAMTT assay10 MOI66.2% cell survival after 48 hoursNoNoNA No responseNACombined therapy increases STAT1, SOCS1 and apoptosisCombined therapy decreases expression of MMP-2, XIAP,OPN and VEGFNA22569271
OV_2568AdenovirusSG600-IL-24+IFNDNAAdenoviridaeDeletion of E1B gene and insertion of IL-24 gene and addition of INYesNoVirus expressing IL-24 gene and IFN geneATCCHuman hepatocellular carcinoma cell lineMHCC97L1000 cellsNAMTT assay10 MOI54.5% cell survival after 72 hoursNoNoNA No responseNACombined therapy increases STAT1, SOCS1 and apoptosisCombined therapy decreases expression of MMP-2, XIAP,OPN and VEGFNA22569271
OV_2569AdenovirusSG600-IL-24+IFNDNAAdenoviridaeDeletion of E1B gene and insertion of IL-24 gene and addition of INYesNoVirus expressing IL-24 gene and IFN geneATCCHuman hepatocellular carcinoma cell lineMHCC97L1000 cellsNAMTT assay10 MOI24% cell survival after 96 hoursNoNoNA No responseNACombined therapy increases STAT1, SOCS1 and apoptosisCombined therapy decreases expression of MMP-2, XIAP,OPN and VEGFNA22569271